GE HealthCare reports Q2 2024: flat revenue, margin expansion, updates guidance

GE HealthCare Technologies Inc.

2024-Q2 EPS reported $1.75 revenue$9,489,000,000

Revenue flat at $4.8B; organic revenue grew 1% YoY; net income margin improved to 8.9% from 8.7%.
Adjusted EBIT margin expanded to 15.3% (up 60 bps); adjusted EPS rose to $1.00 from $0.92.
Full-year organic revenue growth guidance lowered to 1-2% (from ~4%) due to China headwinds; adjusted EBIT margin guidance raised to 15.7-16.0%.
Cash flow from operations was -$119M vs -$67M; free cash flow -$182M vs -$136M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.